Exact Mass: 434.1522
Exact Mass Matches: 434.1522
Found 500 metabolites which its exact mass value is equals to given mass value 434.1522
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flupentixol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Vestitone 7-glucoside
Vestitone 7-glucoside is found in herbs and spices. Vestitone 7-glucoside is a constituent of Glycyrrhiza uralensis (Chinese licorice). Constituent of Glycyrrhiza uralensis (Chinese licorice). Vestitone 7-glucoside is found in herbs and spices.
Melleolide K
Melleolide K is found in mushrooms. Melleolide K is isolated from Armillariella mellea (honey mushroom Isolated from Armillariella mellea (honey mushroom). Melleolide K is found in mushrooms.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide is a conjugate of 4-hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-methyl and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide
4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide is a conjugate of 4-hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-methyl and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)
6-(D-alpha-(3-Guanylureido)phenylacetamido)penicillanic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
chrysoeriol 6-hexoside (use chrysoeriol_6_glucoside.mol)
13-acetoxy-8alpha-angeloyloxy-4alpha,14-dihydroxy-2alpha,3alpha-epoxygermacra-1(10)E,5E,7(11)-trien-12,6-olide
chaetomugilin D
An azaphilone isolated from Chaetomium globosum and has been shown to exhibit inhibitory activity against the brine shrimp (Artemia salina) and Mucor miehei.
2-methoxy-4-hydroxyphenol 1-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside|capparoside A
19-hydroxy-15-desoxy-orientalide|19-hydroxy-15-desoxyorientalide
1-[O-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranosyl]oxy-2-phenol
Chaetoviridin C
An azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a chloro group at position 5, a 3-hydroxy-2-methylbutanoyl group at position 9, a methyl group at position 6a and a 3-methylpent-1-en-1yl group at position 3. It has been isolated from Chaetomium globosum.
1,2-bis-beta-D-glucopyranosyloxy-benzene|1,2-Bis-beta-D-glucopyranosyloxy-benzol|pyrocatechol-O-beta-D-diglucopyranoside
2alpha-hydroxy-9beta-acetoxy-8alpha-(2,3-epoxy-2-methylbutyryloxy)-ludartin|2alpha-hydroxy-9beta-acetoxy-8alpha-<2,3-epoxy-2-methylbutyryloxy>-ludartin
16(-Hydroxy-18-Bromo-8,17,19-tricosatriene-4,6-diynoic acid
2-(3,4-dihydroxyphenyl)ethanol 1-O-[beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside]
bielschowskysin
A diterpenoid that is isolated from Pseudopterogorgia kallos and exhibits antimalarial and anticancer activity.
2-methoxy-4-hydroxyphenol 1-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside|canthoside D
4-hydroxyphenyl beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside
4-hydroxy-3-methoxyphenyl 1-O-beta-D-xylopyranosyl-(1->6)-beta-glucopyranoside|4-hydroxy-3-methoxyphenyl beta-D-xylopyranosyl(1->6)-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenyl beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenyl beta-D-xylopyranosyl-(1->6)-O-beta-D-glucopyranoside
4-Hydroxyphenyl-??-gentiobioside|Hydrochinon-beta-gentiobiosid|p-Hydroxyphenyl-beta-gentiobiosid
methyl ester of phyllaemblic acid|phyllaemblic acid methyl ester
(3R)-3alpha-Hydroxy-4alpha-(2-methylcrotonoyloxy)-6alpha,7beta-dimethyl-7-acetoxy-3,4,4,5,6,6,7,8-octahydrospiro[3H-2-benzopyran-3,2-[2H]pyran]-6,8-dione
2,4-dihydroxy-4-methoxydihydrochalcone-4-O-Beta-D-glucopyranoside
2,4-dihydroxy-4-methoxydihydrochalcone-2-O-Beta-D-glucopyranoside|bauhiniaside A
Ala Glu Ser Glu
Asp Ala Thr Glu
Glu Thr Ala Asp
Catharanthine Sulfate
MLS000876973-01!5-chloro-9-(3-hydroxy-2-methylbutanoyl)-6a-methyl-3-[(E)-3-methylpent-1-enyl]-9,9a-dihydrofuro[2,3-h]isochromene-6,8-dione
3-(4-hydroxy-2,2-dimethyl-1-oxo-3,3a-dihydroimidazo[1,2-a]indol-4-yl)-2-(4-oxoquinazolin-3-yl)propanoic acid
C23H22N4O5_1H-Imidazo[1,2-a]indole-9-propanoic acid, 2,3,9,9a-tetrahydro-9-hydroxy-2,2-dimethyl-3-oxo-alpha-(4-oxo-3(4H)-quinazolinyl)
Ala Cys Asn Gln
Ala Cys Gln Asn
Ala Asp Glu Thr
Ala Asp Thr Glu
Ala Glu Asp Thr
Ala Glu Glu Ser
Ala Glu Thr Asp
Ala Asn Cys Gln
Ala Asn Gln Cys
Ala Gln Cys Asn
Ala Gln Asn Cys
Ala Ser Glu Glu
Ala Thr Asp Glu
Ala Thr Glu Asp
Cys Ala Asn Gln
Cys Ala Gln Asn
Cys Cys Ile Pro
Cys Cys Leu Pro
Cys Cys Pro Ile
Cys Cys Pro Leu
Cys Asp Pro Thr
Cys Asp Thr Pro
Cys Glu Pro Ser
Cys Glu Ser Pro
Cys Gly Gln Gln
Cys Ile Cys Pro
Cys Ile Pro Cys
Cys Leu Cys Pro
Cys Leu Pro Cys
Cys Asn Ala Gln
Cys Asn Gln Ala
Cys Pro Cys Ile
Cys Pro Cys Leu
Cys Pro Asp Thr
Cys Pro Glu Ser
Cys Pro Ile Cys
Cys Pro Leu Cys
Cys Pro Ser Glu
Cys Pro Thr Asp
Cys Gln Ala Asn
Cys Gln Gly Gln
Cys Gln Asn Ala
Cys Gln Gln Gly
Cys Ser Glu Pro
Cys Ser Pro Glu
Cys Thr Asp Pro
Cys Thr Pro Asp
Asp Ala Glu Thr
Asp Cys Pro Thr
Asp Cys Thr Pro
Asp Asp Ser Val
Asp Asp Val Ser
Asp Glu Ala Thr
Asp Glu Thr Ala
Asp Pro Cys Thr
Asp Pro Thr Cys
Asp Ser Asp Val
Asp Ser Val Asp
Asp Thr Ala Glu
Asp Thr Cys Pro
Asp Thr Glu Ala
Asp Thr Pro Cys
Asp Val Asp Ser
Asp Val Ser Asp
Glu Ala Asp Thr
Glu Ala Glu Ser
Glu Ala Ser Glu
Glu Ala Thr Asp
Glu Cys Pro Ser
Glu Cys Ser Pro
Glu Asp Ala Thr
Glu Asp Thr Ala
Glu Glu Ala Ser
Glu Glu Gly Thr
Glu Glu Ser Ala
Glu Glu Thr Gly
Glu Gly Glu Thr
Glu Gly Thr Glu
Glu Pro Cys Ser
Glu Pro Ser Cys
Glu Ser Ala Glu
Glu Ser Cys Pro
Glu Ser Glu Ala
Glu Ser Pro Cys
Glu Thr Asp Ala
Glu Thr Glu Gly
Glu Thr Gly Glu
Gly Cys Gln Gln
Gly Glu Glu Thr
Gly Glu Thr Glu
Gly Met Met Pro
Gly Met Asn Asn
Gly Met Pro Met
Gly Asn Met Asn
Gly Asn Asn Met
Gly Pro Met Met
Gly Gln Cys Gln
Gly Gln Gln Cys
Gly Thr Glu Glu
Ile Cys Cys Pro
Ile Cys Pro Cys
Ile Pro Cys Cys
Leu Cys Cys Pro
Leu Cys Pro Cys
Leu Pro Cys Cys
Met Gly Met Pro
Met Gly Asn Asn
Met Gly Pro Met
Met Met Gly Pro
Met Met Pro Gly
Met Asn Gly Asn
Met Asn Asn Gly
Met Pro Gly Met
Met Pro Met Gly
Asn Ala Cys Gln
Asn Ala Gln Cys
Asn Cys Ala Gln
Asn Cys Gln Ala
Asn Gly Met Asn
Asn Gly Asn Met
Asn Met Gly Asn
Asn Met Asn Gly
Asn Asn Gly Met
Asn Asn Met Gly
Asn Gln Ala Cys
Asn Gln Cys Ala
Pro Cys Cys Ile
Pro Cys Cys Leu
Pro Cys Asp Thr
Pro Cys Glu Ser
Pro Cys Ile Cys
Pro Cys Leu Cys
Pro Cys Ser Glu
Pro Cys Thr Asp
Pro Asp Cys Thr
Pro Asp Thr Cys
Pro Glu Cys Ser
Pro Glu Ser Cys
Pro Gly Met Met
Pro Ile Cys Cys
Pro Leu Cys Cys
Pro Met Gly Met
Pro Met Met Gly
Pro Ser Cys Glu
Pro Ser Glu Cys
Pro Thr Cys Asp
Pro Thr Asp Cys
Gln Ala Cys Asn
Gln Ala Asn Cys
Gln Cys Ala Asn
Gln Cys Gly Gln
Gln Cys Asn Ala
Gln Cys Gln Gly
Gln Gly Cys Gln
Gln Gly Gln Cys
Gln Asn Ala Cys
Gln Asn Cys Ala
Gln Gln Cys Gly
Gln Gln Gly Cys
Ser Ala Glu Glu
Ser Cys Glu Pro
Ser Cys Pro Glu
Ser Asp Asp Val
Ser Asp Val Asp
Ser Glu Ala Glu
Ser Glu Cys Pro
Ser Glu Glu Ala
Ser Glu Pro Cys
Ser Pro Cys Glu
Ser Pro Glu Cys
Ser Val Asp Asp
Thr Ala Asp Glu
Thr Ala Glu Asp
Thr Cys Asp Pro
Thr Cys Pro Asp
Thr Asp Ala Glu
Thr Asp Cys Pro
Thr Asp Glu Ala
Thr Asp Pro Cys
Thr Glu Ala Asp
Thr Glu Asp Ala
Thr Glu Glu Gly
Thr Glu Gly Glu
Thr Gly Glu Glu
Thr Pro Cys Asp
Thr Pro Asp Cys
Val Asp Asp Ser
Val Asp Ser Asp
Val Ser Asp Asp
Idebenone Metabolite (Benzenedecanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-)
Vestitone 7-glucoside
Melleolide K
16-hydroxy-18-bromo-8E,17E19Z-tricosatrien-4,6-diynoic acid
acetyl prop-2-enoate,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol
Glisolamide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
(2R,4S)-4-AMINO-1,2-PYRROLIDINEDICARBOXYLICACID1-(1,1-DIMETHYLETHYL)2-METHYLESTER
N-Benzoyl-DL-arginine-4-nitroanilide hydrochloride
5-[[2,6-Difluoro-4-(trans-4-propylcyclohexyl)phenyl]difluoromethoxy]-1,2,3-trifluorobenzene
[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane
Fluvoxamine maleat
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Namitecan
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents
4-tert-butyl-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide
Niperotidine
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists
chrysoeriol 6-hexoside (use chrysoeriol_6_glucoside.mol)
3-(4-Hydroxy-2,2-dimethyl-1-oxo-3,3a-dihydroimidazo[1,2-a]indol-4-yl)-2-(4-oxoquinazolin-3-yl)propanoic acid
[(2R,2aS,7aS,7bR)-3-formyl-2a-hydroxy-6,6,7b-trimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 3-chloro-4,6-dihydroxy-2-methylbenzoate
[3-Carboxy-2-[4-hydroxy-5-(3-sulfooxyphenyl)pentanoyl]oxypropyl]-trimethylazanium
(2E,4E,6E,8E,10E,12E,14E)-16-oxo-16-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-2,4,6,8,10,12,14-heptaenoic acid
Niperotidina
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist
(-)-(7S,8S,8R)-4,4-dihydroxy-3,3,5,5-tetramethoxy-7,9-epoxylignan-9-ol-7-one
A lignan isolated from the stems of Sinocalamus affinis.
(6aS,7aR,8R,9R,11aR,11bS)-5-chloro-7a-hydroxy-6a,8,9-trimethyl-3-[(1E)-3-methylpent-1-en-1-yl]-6a,7a,8,9,11a,11b-hexahydro-6H,11H-pyrano[3,4:4,5]furo[2,3-h][2]benzopyran-6,11-dione
8-methoxy-3-[4-(pyrrolidin-1-ylcarbonyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrimido[5,4-b]indol-4-one
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-3-(4-fluorophenyl)sulfonyl-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]oxan-2-yl]ethyl]pyrazine-2-carboxamide
N-[(2S,3R,6S)-6-[2-(benzylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]pyrazine-2-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2S,3S,6R)-6-[2-(benzylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]pyrazine-2-carboxamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2R,3S,6S)-6-[2-(benzylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]pyrazine-2-carboxamide
N-[(2R,3R,6S)-6-[2-(benzylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]pyrazine-2-carboxamide
(2R,3R,3aS,9bS)-1-[(2-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
(1S,2aS,8bS)-N-(2-chlorophenyl)-1-(hydroxymethyl)-2-(pyridin-4-ylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(2S,3S,3aR,9bR)-1-[(2-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(phenylmethyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]-2-pyrazinecarboxamide
(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-3-(2-methoxyphenyl)sulfonyl-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
methyl (1S,2R,4R,7E,9R,10R,11S)-9-acetyloxy-4-methyl-12-methylidene-10-(2-methylprop-2-enoyloxy)-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-ene-8-carboxylate
3-[3-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropylamino]propan-1-ol
5-chloro-9-(3-hydroxy-2-methylbutanoyl)-6a-methyl-3-[(E)-3-methylpent-1-enyl]-9,9a-dihydrofuro[2,3-h]isochromene-6,8-dione
4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-methyl-O-glucuronide
Chaetoviridin B
An organic heterotetracyclic compound with formula C23H27ClO6 isolated from Chaetomium globosum. It exhibits antifungal activity against plant pathogenic fungi.
CP-31398 (dihydrochloride)
CP-31398 dihydrochloride stabilizes the active conformation of p53 and promotes p53 activity in cancer cell lines with mutant or wild-type p53[1][2][3].
CVT-12012
CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively.
JJKK 048
JJKK 048 is an ultrapotent and highly selective inhibitor of Monoacylglycerol lipase (MAGL).
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3-methoxyphenoxy)-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
2-(4-hydroxy-3-methoxyphenoxy)-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
5-chloro-9-(3-hydroxy-2-methylbutanoyl)-6a-methyl-3-(3-methylpent-1-en-1-yl)-9h,9ah-furo[2,3-h]isochromene-6,8-dione
1-{6-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}ethanone
3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(1h-indol-6-yl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one
5-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-6-(4-hydroxy-3-methoxyphenoxy)-2-(hydroxymethyl)oxane-3,4-diol
8-(acetyloxy)-11-hydroxy-9,14-dimethyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-9-en-7-yl 2,3-dimethyloxirane-2-carboxylate
(2r,3s,4s,5r,6r)-5-{[(2r,3s)-6-hydroxy-2-[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzofuran-3-yl]oxy}-2-(hydroxymethyl)-6-methoxyoxane-3,4-diol
(1s,10s,12r,13r,14r,17r)-8-chloro-12-hydroxy-10,13,14-trimethyl-5-[(1e,3r)-3-methylpent-1-en-1-yl]-4,11,15-trioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁷]heptadeca-2,5,7-triene-9,16-dione
7-hydroxy-4'-methoxy-7-methyl-6-oxo-1,4,8,8a-tetrahydrospiro[2-benzopyran-3,2'-oxolan]-8-yl 2,4-dihydroxy-6-methylbenzoate
(2r,4ar,7br)-3-formyl-2a-hydroxy-6,6,7b-trimethyl-1h,2h,4ah,5h,7h,7ah-cyclobuta[e]inden-2-yl 3-chloro-4,6-dihydroxy-2-methylbenzoate
methyl (6e)-8-hydroxy-17-methoxy-5-oxo-2,9-bis(prop-1-en-2-yl)-4,12,15,16-tetraoxapentacyclo[9.4.1.1³,⁶.0¹,¹⁴.0¹¹,¹³]heptadec-6-ene-13-carboxylate
methyl 5-(acetyloxy)-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(2r,3s,4s,5r,6s)-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-6-(4-hydroxy-3-methoxyphenoxy)-2-(hydroxymethyl)oxane-3,4-diol
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(4-hydroxy-2-methoxyphenoxy)oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy)oxane-3,4,5-triol
3-{4-[4-(2-carboxyethyl)-2,6-dimethoxyphenoxy]-3,5-dimethoxyphenyl}propanoic acid
(2s)-5,6,7,8-tetramethoxy-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(1r,2r,6r,7r,9r,12s,15r)-14-methyl-5-methylidene-4,10-dioxo-3,11-dioxatetracyclo[7.5.1.0²,⁶.0¹²,¹⁵]pentadec-13-en-7-yl (2r,3s)-3-(acetyloxy)-2-hydroxy-2-methylbutanoate
(3ar,4s,5s,6r,6as,7r,9ar,9br)-5,7-dihydroxy-9-methyl-3-methylidene-2-oxo-4,5,6a,7,9a,9b-hexahydro-3ah-spiro[azuleno[4,5-b]furan-6,2'-oxiran]-4-yl (2e)-2-[(acetyloxy)methyl]but-2-enoate
(3r,3'r,4r,6's,7s)-7-(acetyloxy)-3'-hydroxy-6',7-dimethyl-6,8-dioxo-4h-spiro[2-benzopyran-3,2'-oxan]-4-yl (2e)-2-methylbut-2-enoate
methyl (3as,4s,5s,11ar)-5-(acetyloxy)-10-(hydroxymethyl)-3-methylidene-4-[(2-methylprop-2-enoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
methyl (1r,2r,3s,6e,8s,9r,11s,13r,14s,17r)-8-hydroxy-17-methoxy-5-oxo-2,9-bis(prop-1-en-2-yl)-4,12,15,16-tetraoxapentacyclo[9.4.1.1³,⁶.0¹,¹⁴.0¹¹,¹³]heptadec-6-ene-13-carboxylate
methyl (3as,4s,5s,11ar)-5-(acetyloxy)-4-{[2-(hydroxymethyl)prop-2-enoyl]oxy}-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
4-hydroxyphenyl-β-gentiobioside
{"Ingredient_id": "HBIN010563","Ingredient_name": "4-hydroxyphenyl-\u03b2-gentiobioside","Alias": "NA","Ingredient_formula": "C18H26O12","Ingredient_Smile": "C1=CC(=CC=C1O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10622","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxyphenyl-beta-gentiobiside
{"Ingredient_id": "HBIN010564","Ingredient_name": "4-hydroxyphenyl-beta-gentiobiside","Alias": "NA","Ingredient_formula": "C18H26O12","Ingredient_Smile": "C1=CC(=CC=C1O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31257","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-hydroxysyringaresinol
{"Ingredient_id": "HBIN013797","Ingredient_name": "8-hydroxysyringaresinol","Alias": "NA","Ingredient_formula": "C22H26O9","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C3COC(C3(CO2)O)C4=CC(=C(C(=C4)OC)O)OC","Ingredient_weight": "434.44","OB_score": "NA","CAS_id": "89199-95-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7343","PubChem_id": "145709470","DrugBank_id": "NA"}
8-o-acetylshanzhiside
{"Ingredient_id": "HBIN013842","Ingredient_name": "8-o-acetylshanzhiside","Alias": "NA","Ingredient_formula": "C18H26O12","Ingredient_Smile": "CC(=O)OC1(CC(C2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "509","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}